Just to clarify I am fully aware there is no gold standard that both the clinicians and the algorithm are weighted against. I was stating that the adjudicators agreed 66% of the time before having to bring in a third adjudicator.
At least 70% of the time Resapp agreed with the final assessment of the respiratory illness based upon by the adjudicators.
So I am stating that we are scoring higher results compared to the adjudicators as the adjudicators only agree 66% of the time. So when you ask two clinicians what there opinion was based upon many tests including x ray, sputum etc. Resapp is coming up with higher %
Btw not having a stab or anything but just because I don't post every single day for the last 4 years that I've held this stock doesn't mean you know more about Resapp, stating "new posters making old mistakes"
I do my own due diligence on Resapp, I email Tony regularly when I don't understand something and need clarification. I don't base my knowledge on posts from hotcopper, I do however follow up on things people post on here to see if it has any substance then filter out the garbage.
- Forums
- ASX - By Stock
- RAP
- Upcoming catalysts
Upcoming catalysts, page-164
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online